Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies999
Asceneuron
Asceneuron is a biotech company that develops effective therapeutics for orphan tauopathies and Alzheimer's disease.
Sector
Subsector
Location
total rounds
total raised
Lysosomal Therapeutics
Lysosomal Therapeutics is a company dedicated to research and development in the field of neurodegeneration.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
Acumen Pharmaceuticals
Acumen is developing a drug to treat Alzheimer's disease.
Sector
Subsector
Location
total rounds
total raised
Tranquis Therapeutics
Tranquis Therapeutics develops medicines to treat neurodegenerative and aging-related diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds8
Number of Funding Rounds
Money Raised
Their latest funding was raised on 10.08.2022. Their latest investor National Institute on Aging. Their latest round Grant
National Institute on Aging
The company invests in startups in the education and biotechnology industries.
Sector
Subsector
Location
count Of Investments
National Institutes of Health
NIH conducts research to improve health and reduce illness and disability.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Co-Investors
Investors6
Number of lead investors
Number of investors
National Institute on Aging
The company invests in startups in the education and biotechnology industries.
Sector
Subsector
Location
count Of Investments
National Institutes of Health
NIH conducts research to improve health and reduce illness and disability.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Wheatley MedTech Partners
Wheatley MedTech Partners is a New York-based venture capital fund.
Sector
Subsector
count Of Investments
People
Founders2
Eliot J. Davidowitz
Davidowitz has 20+ years of experience in academic and industrial research and development. Prior to founding Oligomerix, he was a Senior Scientist and Laboratory Manager at Q-RNA, Inc. Dr. Davidowitz received his B.S. from Cornell University, Ph.D. from Case Western Reserve University and completed an NIH postdoctoral fellowship at Albert Einstein College of Medicine. His academic work was in molecular and cellular biology and his industrial experience has focused on assay development for drug discovery targeting tau protein for Alzheimer’s disease.
current job
organization founded
Eliot J. Davidowitz
James Moe
Moe has 20+ years industrial experience having held senior management positions in product development working on international teams in both early and late stage diagnostic, biotechnology and biopharmaceutical companies including Gene-Trak/Amoco Technology Ventures/Vysis, bioMerieux, and Mosaic Technologies. Prior to founding Oligomerix, he was Director of Product Development at Pyrosequencing, Senior Molecular Biologist at Spire Biomedical, and Director of Product Development at Q-RNA, Inc. Dr. Moe received his Ph.D. degree in Molecular Biology/Molecular Biophysics from Wesleyan University, did his postdoctoral studies at Vanderbilt University in the Center for Molecular Toxicology where he was jointly appointed in the Biochemistry Department in the Medical School, and the Chemistry Department in the College of Arts and Sciences, and has an MBA degree with a concentration in entrepreneurial studies from Boston University.
current job
organization founded
James Moe
Employee Profiles6
James Moe
Co-Founder & CEO , Director, Principal Investigator